The tale of two epidemics - Sinéad Delany-Moretlwe

Why should violence prevention form an essential part of an HIV prevention response for young women? Gender-based violence (GBV) increases HIV risk which in turn has marked impact on the continuum of HIV prevention, treatment and care.

For this webinar, Dr Sinéad Delany-Moretlwe adapts her plenary presentation from the South African AIDS Conference (9-12 June 2015, Durban). There, participants ranging from USAID to local community-based organisations responded to this crystallisation of key STRIVE analysis. In addition to her own work on adolescent girls’ HIV risk and resilience, Dr Delany-Moretlwe synthesises discussions from STRIVE's high-level consultation on violence against women and girls and HIV, Greentree II, (12-14 May 2015, Greentree Estate, New York).

Dr Delany-Moretlwe is Director of Research at Wits RHI. Her focus is on the prevention and control of sexually transmitted infections including HIV. She has led several international multi-centre trials of new technologies for HIV prevention, including genital herpes treatment and novel microbicides, as well as the FACTS 001 trial.

Download the pdf of the presentation here.

Filter by